NDC 0074-2310 – Rinvoq
Upadacitinib 30 mg/1 · Tablet, Extended Release · Oral
Product NDC0074-2310
Product details
- Brand name
- Rinvoq
- Generic name
- Upadacitinib
- Labeler
- AbbVie Inc.
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- NDA · NDA211675
- Marketed since
- August 16, 2019
- Listing expires
- December 31, 2027
- Pharmacologic class
- Janus Kinase Inhibitor
Active ingredients
- Upadacitinib 30 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0074-2310-20 sample | 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2310-20) | Aug 16, 2019 |
| 0074-2310-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2310-30) | Aug 16, 2019 |